Aloxi

What is ALOXI®?

ALOXI® (palonosetron hydrochloride) is a 5-HT3 antagonist.

ALOXI® obtained a centralised registration in Europe in 2005, with an indication for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

What does ALOXI® do?

Download Product characteristics

Download Patient information leaflet

ALOXI® enquiries

How to order ALOXI®:

UK

Mawdsleys
Unit 7
Parkway One Business Centre
Parkway Drive
Sheffield
S9 4WU
Tel: +44 (0)114 244 0321
Fax: +44 (0)114 243 6054
http://www.mawdsleys.co.uk/                          

E-mail: dave.hopkinson@mawdsleys.co.uk

For any other information relating to ALOXI® please contact:

Telephone: +44 (0) 1244 625152
Email: enquiries@sinclairispharma.com